Patents by Inventor Isidore Faiferman

Isidore Faiferman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a p38 kinase inhibitor for treating psychiatric disorders
    Patent number: 7989479
    Abstract: The use of 6-(S-Cyclopropylcarbamoyl-S-fluoro-2-methyl-phenyl)-N-(2,2-dimethylproyl)-nicotinamide, which is known in the art as a p38 kinase inhibitor in the treatment or prophlaxis of one or more psychiatric disorders.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: August 2, 2011
    Assignee: GlaxoSmithKline LLC
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo Pich, Emiliangelo Ratti, Paul Bryan Wren
  • Novel Compounds
    Publication number: 20100144755
    Abstract: Novel substituted 2,4,8-trisubstituted 8H-pyrido[2,3-d]pyrimidin-7-one containing compounds and compositions, and their use use in therapy as CSBP/RK/p38 kinase inhibitors.
    Type: Application
    Filed: June 15, 2007
    Publication date: June 10, 2010
    Applicant: Glaxo Group Limited
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo-Pich, Emiliangelo Ratti, Paul Bryan Wren
  • "NOVEL COMPOUNDS"
    Publication number: 20100069409
    Abstract: Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, and 1,5,7-trisubstituted-3,4-dihydro-pyrimido[4,5-d]pyrimidin-2-(M)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.
    Type: Application
    Filed: June 15, 2007
    Publication date: March 18, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo-Pich, Emiliangelo Ratti, Paul Bryan Wren
  • Use of a p38 Kinase Inhibitor for Treating Psychiatric Disorders
    Publication number: 20100016377
    Abstract: The use of 6-(S-Cyclopropylcarbamoyl-S-fluoro-2-methyl-phenyl)-N-(2,2-dimethylproyl)-nicotinamide, which is known in the art as a p38 kinase inhibitor in the treatment or prophlaxis of one or more psychiatric disorders.
    Type: Application
    Filed: June 13, 2007
    Publication date: January 21, 2010
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo Pich, Emiliangelo Ratti, Paul Bryan Wren
  • NOVEL COMPOUNDS
    Publication number: 20090318424
    Abstract: Novel substituted 1,5,7-trisubstituted-3,4-dihydro-pyrimido[4,5-d]pyrimidin-2-(1H)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.
    Type: Application
    Filed: June 15, 2007
    Publication date: December 24, 2009
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo-Pich, Emiliangelo Ratti, Paul Bryan Wren